Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 48051-48100 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05312983
Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss
NA
Recruiting
700 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2030
1 condition
3 sponsors
2 locations
NCT05456893
A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies
N/A
Recruiting
95 participants
Started: Jul 28, 2022 · Completed: Sep 9, 2027
2 conditions
1 sponsor
1 location
NCT06870942
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
PHASE2
Recruiting
35 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05327608
Neoadjuvant Breast Cancer Time Restricted Eating
NA
Recruiting
55 participants
Started: Jul 28, 2022 · Completed: May 1, 2027
7 conditions
1 sponsor
1 location
NCT05481723
Lung Ultrasound-guided Hemodynamic Optimization
PHASE3
Recruiting
350 participants
Started: Jul 28, 2022 · Completed: Aug 31, 2027
3 conditions
1 sponsor
1 location
NCT05393622
Brain Stimulation for Severe Depression
NA
Recruiting
20 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05908682
Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
N/A
Recruiting
100 participants
Started: Jul 28, 2022 · Completed: Oct 31, 2029
3 conditions
2 sponsors
1 location
NCT05555693
Correlation Between Postoperative Cognitive-related Adverse Reactions and Brain Metabolomic Characteristics in Elderly Patients
N/A
Recruiting
200 participants
Started: Jul 27, 2022 · Completed: Dec 1, 2027
1 condition
1 sponsor
1 location
NCT05072314
Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
PHASE3
Recruiting
4,300 participants
Started: Jul 27, 2022 · Completed: Jul 31, 2028
4 conditions
2 sponsors
43 locations
NCT05353439
Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer
PHASE1
Recruiting
60 participants
Started: Jul 27, 2022 · Completed: Apr 1, 2027
6 conditions
1 sponsor
14 locations
NCT05400317
A Study to Evaluate the Efficacy and Safety of AD-218
PHASE3
Recruiting
520 participants
Started: Jul 27, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05168605
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
NA
Recruiting
100 participants
Started: Jul 27, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05180773
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
PHASE4
Recruiting
250 participants
Started: Jul 27, 2022 · Completed: Dec 31, 2028
1 condition
2 sponsors
64 locations
NCT04765514
Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients
PHASE2
Recruiting
121 participants
Started: Jul 27, 2022 · Completed: Jun 30, 2032
1 condition
1 sponsor
2 locations
NCT05273788
Thoracic Neuromodulation for Diabetic Gastroparesis
PHASE1
Recruiting
48 participants
Started: Jul 27, 2022 · Completed: May 31, 2026
1 condition
3 sponsors
1 location
NCT05244239
Palliative Radiotherapy with Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer
PHASE1
Recruiting
22 participants
Started: Jul 27, 2022 · Completed: Jul 28, 2025
2 conditions
3 sponsors
3 locations
NCT05442060
To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer
PHASE2
Recruiting
60 participants
Started: Jul 27, 2022 · Completed: May 31, 2026
1 condition
1 sponsor
7 locations
NCT05367037
Physiological Ventricular Pacing Vs Managed Ventricular Pacing for Persistent AF Prevention in Prolonged AV Interval
NA
Recruiting
640 participants
Started: Jul 27, 2022 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT05434598
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
NA
Recruiting
60 participants
Started: Jul 27, 2022 · Completed: Aug 31, 2027
2 conditions
3 sponsors
1 location
NCT04928508
Advanced or Recurrent Solid Tumors Treated With SHetA2
PHASE1
Recruiting
50 participants
Started: Jul 27, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT06909877
Study to Evaluate Efficacy and Safety of HH2853 in Relapsed/Refractory Peripheral T-cell Lymphoma
PHASE1/PHASE2
Recruiting
100 participants
Started: Jul 27, 2022 · Completed: Jul 30, 2027
1 condition
1 sponsor
1 location
NCT05053113
Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive Women
NA
Recruiting
500 participants
Started: Jul 27, 2022 · Completed: Aug 31, 2025
1 condition
2 sponsors
1 location
NCT06075160
Resting Full-cycle Ratio (RFR)-Guided Revascularization
N/A
Recruiting
1,167 participants
Started: Jul 27, 2022 · Completed: Dec 31, 2026
1 condition
12 sponsors
1 location
NCT05407909
To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid Tumors
PHASE1
Recruiting
176 participants
Started: Jul 27, 2022 · Completed: Jan 6, 2026
1 condition
1 sponsor
1 location
NCT05422066
Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma
PHASE2
Recruiting
50 participants
Started: Jul 26, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
6 locations
NCT05404945
Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above
PHASE2
Recruiting
44 participants
Started: Jul 26, 2022 · Completed: Oct 3, 2027
1 condition
2 sponsors
3 locations
NCT05229614
Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease
PHASE2
Recruiting
27 participants
Started: Jul 26, 2022 · Completed: Aug 31, 2026
4 conditions
4 sponsors
4 locations
NCT05165511
Families, Responsibility, Education, Support, and Health for Executive Function
NA
Recruiting
30 participants
Started: Jul 26, 2022 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06163365
Inherited Cancer Early Diagnosis (ICED) Study
N/A
Recruiting
100 participants
Started: Jul 26, 2022 · Completed: Jul 26, 2025
8 conditions
1 sponsor
1 location
NCT05472558
Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL
PHASE1
Recruiting
48 participants
Started: Jul 26, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05377658
AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer
PHASE2
Recruiting
43 participants
Started: Jul 26, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06083636
Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine
N/A
Recruiting
500 participants
Started: Jul 26, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05476432
HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study
PHASE3
Recruiting
300 participants
Started: Jul 26, 2022 · Completed: Oct 1, 2026
1 condition
3 sponsors
3 locations
NCT04591002
Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)
PHASE2
Recruiting
43 participants
Started: Jul 26, 2022 · Completed: Oct 30, 2028
1 condition
1 sponsor
2 locations
NCT04671212
Discarded Bone Marrow for Hematology Research
N/A
Recruiting
50 participants
Started: Jul 26, 2022 · Completed: Jan 31, 2035
1 condition
1 sponsor
1 location
NCT05357144
AmbassADDOrs for Health Study
NA
Recruiting
140 participants
Started: Jul 26, 2022 · Completed: Dec 31, 2026
1 condition
5 sponsors
2 locations
NCT04078555
A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer
PHASE2
Recruiting
80 participants
Started: Jul 26, 2022 · Completed: Jun 15, 2025
1 condition
1 sponsor
1 location
NCT05586984
Transvaginal Sacrospinous Hysteropexy Versus Laparoscopic Uterine Lateral Suspension
N/A
Recruiting
90 participants
Started: Jul 26, 2022 · Completed: Dec 31, 2029
2 conditions
1 sponsor
1 location
NCT05013736
Baby Brain Recovery Study
N/A
Recruiting
65 participants
Started: Jul 26, 2022 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT05320926
Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial
NA
Recruiting
3,744 participants
Started: Jul 26, 2022 · Completed: Jul 10, 2028
1 condition
1 sponsor
1 location
NCT05571384
High Intensity Body-weight Circuit Training Feasibility and Efficacy for in Middle Aged Persons With Type 2 Diabetes
NA
Recruiting
42 participants
Started: Jul 26, 2022 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT05657067
Effectiveness and Feasibility of Structured EFFT
NA
Recruiting
15 participants
Started: Jul 26, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT05528458
Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma
PHASE2
Recruiting
59 participants
Started: Jul 26, 2022 · Completed: Dec 1, 2029
1 condition
1 sponsor
1 location
NCT04906213
CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients
PHASE2
Recruiting
72 participants
Started: Jul 25, 2022 · Completed: Aug 31, 2026
2 conditions
1 sponsor
1 location
NCT06085794
Standard PCNL Vs Endoscopic Combined Intrarenal Surgery (ECIRS) for Complex Nephrolithiasis in Obese Patients
NA
Recruiting
100 participants
Started: Jul 25, 2022 · Completed: Jan 31, 2024
1 condition
1 sponsor
1 location
NCT06549621
Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy
N/A
Recruiting
66 participants
Started: Jul 25, 2022 · Completed: Oct 25, 2024
1 condition
1 sponsor
1 location
NCT05366829
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
PHASE2
Recruiting
35 participants
Started: Jul 25, 2022 · Completed: Jun 1, 2027
2 conditions
3 sponsors
2 locations
NCT05186064
Glioblastoma Targeted Treatment Option Maximization by WGS
NA
Recruiting
160 participants
Started: Jul 25, 2022 · Completed: Jul 1, 2025
1 condition
12 sponsors
1 location
NCT05263180
A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors.
PHASE1
Recruiting
30 participants
Started: Jul 25, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
4 locations
NCT05501262
Comparative Effectiveness of Cryoablation Versus Steroid and Lidocaine Alone for Treatment of Morton's Neuroma
NA
Recruiting
32 participants
Started: Jul 25, 2022 · Completed: Dec 31, 2027
1 condition
3 sponsors
1 location
Previous
1
More pages
959
960
961
962
963
964
965
More pages
1333
Next